Back to search

United States· US:43598-478_85e37025-d239-e504-38a0-c2db7ffa0100

Sevelamer Carbonate for Oral Suspension

A sevelamer product containing sevelamer carbonate, registered in United States by Dr. Reddys Laboratories Inc. The same ATC class is registered in 18 of our 19 countries.

ATC V03AE02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSevelamer Carbonate for Oral Suspensi…ATCV03AE02REGISTER NO.US:43598-478_85e37025…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Sevelamer is registered in 18 of 19 countries.

Countries holding a registration under ATC V03AE02 (sevelamer), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose

Sevelamer · ATC V03AE02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sevelamer costs, country by country.

Normalised to the WHO defined daily dose (6.4 g), the median price runs from $3.42 in France to $9.10 in Switzerland — a ×2.7 gap.

  • United States: $5.56 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Sevelamer · price per daily dose (6.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$9.10
  • ES Spain$6.97
  • IT Italy$5.92
  • US United States$5.56 (acquisition cost)
  • FR France$3.42
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SEVELAMER CARBONATE
Manufacturer
Dr. Reddys Laboratories Inc
Country
United States (US)
ATC code
V03AE02
ATC class
Sevelamer
Defined daily dose
6.4 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    43598-478-90
  • ndc11
    4359847890
    90 PACKET in 1 CARTON (43598-478-90) / 1 POWDER, FOR SUSPENSION in 1 PACKET (43598-478-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

293 interactions on record for sevelamer.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sevelamer · interactions on record

293 records

  • 2 severe
  • 31 moderate
  • 258 info

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • ErgocalciferolA11CC01moderate
  • DihydrotachysterolA11CC02moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sevelamer in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sevelamer products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Sevelamer Ratiopharm, Sevelamer Sandoz
  • Belgium · Sevelamer Carbonate Ab, Sevelamer-Carbonaat Genthon
  • Bulgaria · Sevelamer Sandoz, Севеламер Карбонат Heaton
  • Cyprus · Sevelamer Ledpharm
  • Czechia · Sevelamer Carbonate Heaton, Sevelamer Carbonate Viatris
  • Germany · Sevelamercarbonat Al, Sevelamercarbonat Axiromed
  • Denmark · Lovtelar, Sevelamer Sandoz
  • Estonia · Sevelamer Auxilia
  • Spain · Fosquel, Lovtelar
  • Finland · Sevelamer Avansor
  • France · Lovtelar, Sevelamer Carbonate Arrow
  • United Kingdom (Northern Ireland) · Sevelamer Carbonate, Sevelamer Carbonate Aspire Pharma
  • Greece · Lovtelar, Sevelamer Demo
  • Croatia · Sevelamer Sandoz, Sevelamerkarbonat Pliva
  • Hungary · Sevelamer Carbonate Pharmsol, Sevelamer Mensana Pharma
  • Ireland · Sevelamer Carbonate Generics, Sevelamer Carbonate Genthon
  • Iceland · Renvela, Sevelamer Carbonate Winthrop
  • Italy · Lovtelar, Sevelamer Aurobindo
  • Liechtenstein · Renvela, Sevelamer Carbonate Winthrop
  • Luxembourg · Sevemed
  • Latvia · Sevelamer Carbonate Sandoz, Sevelamer Carbonate Synthon
  • Netherlands · Sevelameercarbonaat Sandoz, Sevelameercarbonaat Viatris
  • Norway · Renvela, Sevelamer Carbonate Winthrop
  • Poland · Sewelameru Węglan Synthon
  • Portugal · Sevelâmero Generis, Sevelâmero Mylan
  • Romania · Carbonat De Sevelamer Heaton
  • Sweden · Sevelamer Medical Valley, Sevelamer Sandoz
  • Slovenia · Sevelamer Lek
  • Slovakia · Sevelamer Carbonate Heaton, Sevelamer Carbonate Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df51e659-5160-4ebc-aa04-2ebde174b965
GET /v1/drugs/df51e659-5160-4ebc-aa04-2ebde174b965?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "800",
  "substance": "SEVELAMER CARBONATE",
  "productndc": "43598-478",
  "dosage_form": "POWDER, FOR SUSPENSION",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA210464",
  "marketing_category": "ANDA"
}

See everything about sevelamer.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.